Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
04/18/1996 | WO1996011002A1 Antiinflammatory agent for external use |
04/18/1996 | WO1996010995A1 Enteric film coating compositions, method of coating therewith, and coated forms |
04/18/1996 | WO1996010994A1 Process for the preparation of colon specific reduction sensitive polymers |
04/18/1996 | WO1996010992A1 Preparation of protein microspheres, films and coatings |
04/18/1996 | WO1996010989A1 Use and composition of an anti-sexually transmitted diseases formulation |
04/18/1996 | CA2202472A1 Hematopoietic cell l-selectin ligand (hll) and therapeutics thereof |
04/18/1996 | CA2202272A1 Treatment of tissues to reduce subsequent response to injury |
04/18/1996 | CA2201966A1 Process for the preparation of colon specific reduction sensitive polymers |
04/18/1996 | CA2201872A1 Use and composition of an anti-sexually transmitted diseases formulation |
04/18/1996 | CA2201722A1 Antiinflammatory agent for external use |
04/18/1996 | CA2201721A1 Microorganisms as therapeutic delivery systems |
04/18/1996 | CA2201628A1 Parenteral pharmaceutical compositions containing gf120918a |
04/18/1996 | CA2201132A1 Cytokine designated lerk-6 |
04/17/1996 | EP0706821A1 Method of coating particles |
04/17/1996 | EP0706802A2 A method of preserving ophthalmic solutions and compositions therefor |
04/17/1996 | EP0706799A2 Immunoconjugates II |
04/17/1996 | EP0706798A1 Pharmaceutical composition containing biologically active peptide or protein |
04/17/1996 | EP0706656A1 Immunoassay for soluble fibrin polymers |
04/17/1996 | EP0706581A1 Dna profiles as an indicator of cellular redox potential and cancer risk |
04/17/1996 | EP0706576A1 A method for introducing a biological substance into a target |
04/17/1996 | EP0706573A1 Protein tyrosine kinase and ligands thereof |
04/17/1996 | EP0706563A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
04/17/1996 | EP0706528A1 Fucosylated glycosides as inhibitors of bacterial adherence |
04/17/1996 | EP0706401A1 Drug system |
04/17/1996 | EP0706398A1 Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters |
04/17/1996 | EP0706394A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
04/17/1996 | EP0706383A1 Compositions for inhalation |
04/17/1996 | EP0706382A1 Therapeutic preparation for inhalation |
04/17/1996 | EP0706380A1 Encapsulated medicine |
04/17/1996 | EP0706379A1 Soft gelatin capsule shell compositions |
04/17/1996 | EP0706378A1 New pharmaceutical formulation |
04/17/1996 | EP0706377A1 Sustained release excipient |
04/17/1996 | EP0706375A1 Proteinoid carriers |
04/17/1996 | EP0706372A1 In situ gel for therapeutic use |
04/17/1996 | EP0706370A1 Stable topical retinoid compositions |
04/17/1996 | EP0683665A4 Magnetically responsive composition for carrying biologically active substances and methods of production and use. |
04/17/1996 | EP0621776B1 Injectable composition containing collagen microcapsules |
04/17/1996 | EP0577817B1 Water-in-oil emulsion stable in the course of time, with high silicone content |
04/17/1996 | EP0553299B1 Efficient microcapsule preparation and method of use |
04/17/1996 | EP0429534B1 Molecular conjugates containing cell membrane-blending agents |
04/17/1996 | EP0413828B1 Solid preparation of active vitamin d3 having improved stability |
04/17/1996 | EP0401271B1 Antigen against diabetes |
04/17/1996 | CN1120468A Multi dentate heterodesmic Rh catalyst and its prepn. method |
04/17/1996 | CN1120467A Prodn. of carbon molecular sieve from nut shell (seed) for producing nitrogen by air separation |
04/17/1996 | CN1120458A Physiologically active peptide compositions |
04/17/1996 | CN1120457A Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
04/16/1996 | US5508276 Having duloxetine core, hydroxypropyl methyl cellulose acetate succinate enteric layer |
04/16/1996 | US5508268 Oxidatively stable solution; antibiotic anticancer agent |
04/16/1996 | US5508190 Capable of producing polysaccharides; used as humectant, film forming agent, an emulsifer, a foam stabilizer, water-retaining agent and cement admixture |
04/16/1996 | US5508060 Swelling polymer substrate in supercritical fluid so that carrier and additive penetrates and is trapped within polymer |
04/16/1996 | US5508044 Controlled release form and hydrochlorothiazide immediate release form; treatment of hypertension |
04/16/1996 | US5508043 Sodium alginate and a calcium salt which crosslinks with the alginate when exposed to aqueous solutions; administered orally with a higher aliphatic alcohol |
04/16/1996 | US5508042 Administering an oral dosage every 12 hours |
04/16/1996 | US5508041 Microencapsulation for controlled oral drug delivery system |
04/16/1996 | US5508039 Controlled transdermal administration of melatonin |
04/16/1996 | US5508022 Gelled emulsion particles and compositions in which they are present |
04/16/1996 | US5508021 Biocompatible crosslinked polymer containing imaging agent |
04/16/1996 | CA2018230C Aqueous folinate solution - stable at refrigerator temperature, as well as process for its preparation |
04/11/1996 | WO1996010593A1 PROCESS FOR PREPARING AQUEOUS SOLUTIONS OF POLY(N-VINYL-ε-CAPROLACTAM) AND THEIR USE |
04/11/1996 | WO1996010585A1 Glycosylated protein-liposome conjugates and methods for their preparation |
04/11/1996 | WO1996010557A1 Ceramide 3 derivatives based on monounsaturated fatty acids |
04/11/1996 | WO1996010555A1 Cationic transport reagents |
04/11/1996 | WO1996010424A1 Cellular immunity-inducing conjugate |
04/11/1996 | WO1996010422A1 Conjugate for treating inflammatory diseases |
04/11/1996 | WO1996010421A1 Vaccine compositions |
04/11/1996 | WO1996010406A1 Pharmaceutical composition of fantofarone for oral administration |
04/11/1996 | WO1996010392A1 Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
04/11/1996 | WO1996010391A1 Polyethylene glycol modified ceramide lipids and liposome uses thereof |
04/11/1996 | WO1996010390A1 Novel compositions for the introduction of polyanionic materials into cells |
04/11/1996 | DE4436164A1 New conjugates of tetra:carbohydrate and amide-linked peptide or dye etc. |
04/11/1996 | DE4435563A1 Gel from hyaluronic acid and plant oil |
04/11/1996 | CA2160100A1 Carbohydrate conjugates as inhibitors of cell adhesion |
04/10/1996 | EP0705601A1 Anthraquinones containing solutions for parenteral administration |
04/10/1996 | EP0705599A1 Use of N-(hydroxyalkyl)-substituted alkyl carbamates as tensioactive agents in cosmetic composition |
04/10/1996 | EP0705335A1 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
04/10/1996 | EP0705255A1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes |
04/10/1996 | EP0705096A1 Surface-modified albumin microspheres and pharmaceutical compositions containing them |
04/10/1996 | EP0705085A1 Molecular transdermal transport system |
04/10/1996 | EP0579703B1 Inhibition of aggregation of drug containing particles |
04/10/1996 | EP0512095B1 Methyl pyrrolidinone chitosan, production process and uses thereof |
04/10/1996 | EP0352295B2 Biodadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents |
04/10/1996 | CN1120311A Pharmaceutical composition containing lipophilic drugs |
04/10/1996 | CN1120310A Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces |
04/09/1996 | US5506343 Antibodies specific for the DF3 carcinoma associated antigen |
04/09/1996 | US5506337 Morpholino-subunit combinatorial library and method |
04/09/1996 | US5506248 Salt of ifetroban and one or more basifying agents |
04/09/1996 | US5506230 Oil in water emulsion consists of 2,3-dihydro-1h indene cmpound, an oil, phospholipid as an emulsifier, glycerol as an isotonic agent and water; useful for improving anoxemic and hypoxic syndromes, prevents arrythemia and heart failure |
04/09/1996 | US5506222 Method and composition for treating increased androgenic activity |
04/09/1996 | US5506216 Cyclodextrin-biocide complex |
04/09/1996 | US5506206 Arginine-proline-hydroxyproline-glycine-thienylalanine-serine -(4-methyl-tyrosine)-arganine or a conformational analogue, used as therapeutical or diagnostic agents |
04/09/1996 | US5506203 Systemic administration of a therapeutic preparation |
04/09/1996 | US5506135 Fab fragment, having specificities against fibrin and thrombolytic substances |
04/09/1996 | US5505966 Therapeutical composition and process for its preparation |
04/09/1996 | US5505965 Coating with propylene glycol and a carrier selected from titanium dioxide, zinc oxide and aluminum hydroxide; improves sunburn protection factor |
04/09/1996 | US5505961 Increasing solubility |
04/09/1996 | US5505959 Pharmaceutical composition in gel form in a dispensing package |
04/09/1996 | US5505954 Also containing carboxypolymethylene, edta; preventing secondary hemorrhage |
04/09/1996 | US5505935 Ethylene-vinyl acetate copolymer, acrylic polymer, sunscreen agent |
04/09/1996 | US5505932 Method for the preparation of fluorocarbon-containing polymeric shells for medical imaging |
04/09/1996 | CA1338235C Esters of alginic acid |